{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:18:59Z","timestamp":1787170739661,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":308,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1002\/rth2.12628","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T04:27:07Z","timestamp":1645936027000},"page":"e12628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Safety and effectiveness of recombinant factor XIII\u2010A2 in congenital factor XIII deficiency: Real\u2010world evidence"],"prefix":"10.1016","volume":"6","author":[{"given":"Lone Hvitfeldt","family":"Poulsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1756-8271","authenticated-orcid":false,"given":"Bryce A.","family":"Kerlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4973-1317","authenticated-orcid":false,"given":"Giancarlo","family":"Castaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8078-8402","authenticated-orcid":false,"given":"Angelo Claudio","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8527-7556","authenticated-orcid":false,"given":"Marzia","family":"Menegatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohan","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May\u2010Lill","family":"Garly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5350-1763","authenticated-orcid":false,"given":"Manuel","family":"Carcao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12628_bb0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2516.2004.00944.x","article-title":"The rare coagulation disorders\u2013review with guidelines for management from the United Kingdom Haemophilia Centre Doctors\u2019 Organisation","volume":"10","author":"Bolton\u2010Maggs","year":"2004","journal-title":"Haemophilia"},{"key":"10.1002\/rth2.12628_bb0015","first-page":"59","article-title":"Developing the first recombinant factor XIII for congenital factor XIII deficiency: clinical challenges and successes","volume":"43","author":"Carcao","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1002\/rth2.12628_bb0020","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2011-10-386045","article-title":"Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency","volume":"119","author":"Inbal","year":"2012","journal-title":"Blood"},{"key":"10.1002\/rth2.12628_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/blood-2005-02-0788","article-title":"Safety and pharmacokinetics of recombinant factor XIII\u2010A2 administration in patients with congenital factor XIII deficiency","volume":"108","author":"Lovejoy","year":"2006","journal-title":"Blood"},{"key":"10.1002\/rth2.12628_bb0030","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/jth.13772","article-title":"Minimal factor XIII activity level to prevent major spontaneous bleeds","volume":"15","author":"Menegatti","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12628_bb0035","unstructured":"World Federation of Haemophilia. Report on annual global survey 2018. http:\/\/www1.wfh.org\/publications\/files\/pdf\u20101731.pdf. Accessed November 17, 2020."},{"key":"10.1002\/rth2.12628_bb0040","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/j.1538-7836.2012.04844.x","article-title":"Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12628_bb0045","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1542\/peds.109.2.e32","article-title":"Delayed umbilical bleeding\u2013a presenting feature for factor XIII deficiency: clinical features, genetics, and management","volume":"109","author":"Anwar","year":"2002","journal-title":"Pediatrics"},{"key":"10.1002\/rth2.12628_bb0050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-0038-1624581","article-title":"Recombinant FXIII (rFXIII\u2010A2) prophylaxis prevents bleeding and allows for surgery in patients with congenital FXIII A\u2010subunit deficiency","volume":"118","author":"Carcao","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12628_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ijlh.12756","article-title":"Factor XIII deficiency diagnosis: challenges and tools","volume":"40","author":"Karimi","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"10.1002\/rth2.12628_bb0060","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/jth.13491","article-title":"Advances in the treatment of bleeding disorders","volume":"14","author":"Peyvandi","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12628_bb0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/hae.12505","article-title":"Pharmacokinetics and safety of plasma\u2010derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency","volume":"21","author":"Nugent","year":"2015","journal-title":"Haemophilia"},{"key":"10.1002\/rth2.12628_bb0070","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/jth.12739","article-title":"Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A\u2010subunit deficiency","volume":"12","author":"Kerlin","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12628_bb0075","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/jth.13748","article-title":"Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII\u2010A deficiency: international phase 3b trial results","volume":"15","author":"Kerlin","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12628_bb0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/hae.12224","article-title":"Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients","volume":"20","author":"Williams","year":"2014","journal-title":"Haemophilia"},{"key":"10.1002\/rth2.12628_bb0085","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/hae.12616","article-title":"Pharmacokinetic characterization of recombinant factor XIII (FXIII)\u2010A2 across age groups in patients with FXIII A\u2010subunit congenital deficiency","volume":"21","author":"Brand\u2010Staufer","year":"2015","journal-title":"Haemophilia"},{"key":"10.1002\/rth2.12628_bb0090","unstructured":"WMA Declaration of Helsinki \u2010 ethical principles for medical research involving human subjects. 2016. https:\/\/www.wma.net\/policies\u2010post\/wma\u2010declaration\u2010of\u2010helsinki\u2010ethical\u2010principles\u2010for\u2010medical\u2010research\u2010involving\u2010human\u2010subjects\/. Accessed November 17, 2020."},{"key":"10.1002\/rth2.12628_bb0095","unstructured":"Guidelines for good pharmacoepidemiology practices (GPP). 2007. https:\/\/www.pharmacoepi.org\/resources\/policies\/guidelines\u201008027\/. Accessed November 17, 2020."},{"key":"10.1002\/rth2.12628_bb0100","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1111\/hae.12591","article-title":"The use of recombinant factor XIII in a major bleeding episode of a patient with congenital factor XIII deficiency\u2013the first experience","volume":"21","author":"\u00c1roksz\u00e1ll\u00e1si","year":"2015","journal-title":"Haemophilia"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12628","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12628","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922011530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922011530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:23:28Z","timestamp":1762863808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922011530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2475037922011530"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12628","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and effectiveness of recombinant factor XIII\u2010A2 in congenital factor XIII deficiency: Real\u2010world evidence","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}],"article-number":"e12628"}}